Top Performers in Indian Markets: Gland Pharma, Coforge, and PB Fintech Lead Gains
Indian Stocks Rebound on Tech and Pharma Strength
Indian stocks staged a dramatic late-hour recovery on Monday, May 18, as strong buying in tech stocks and pharma shares offset weakness in financials, auto, and metal counters. The NIFTY 50 benchmark index ended the session with a marginal gain of 0.03% at 23,649, while the BSE Sensex closed at 75,263, up 0.03% from the previous close.
The broader market, however, remained under pressure, with the Nifty Midcap 100 and Nifty Smallcap 100 falling 0.22% and 1.26%, respectively, underperforming the benchmark indices. The resilience of tech and pharma stocks was a key factor in the market's recovery, as these sectors have been among the most resilient in recent sessions.
The Indian rupee continued to depreciate, slipping to a new record low of 96.39 against the US dollar. This marks the continuation of a streak of historic lows in recent sessions, with the currency being weighed down by a stronger greenback and elevated crude oil prices. The sustained selling by overseas investors has further exacerbated the currency's woes, as foreign investors continue to pull money out of domestic equities amid concerns over an economic slowdown.
According to NSDL data, foreign portfolio investors (FPIs) have sold more than ₹2.16 lakh crore worth of Indian equities so far in 2026, surpassing the ₹1.66 lakh crore sold during the entire calendar year 2025.
The prolonged stalemate between the US and Iran continues to cast a shadow over near-term sentiment, yet the equity market managed to recover intraday losses and close on a flat note, supported by value buying in IT and banking stocks. A meaningful breakthrough in diplomatic negotiations with Iran, particularly regarding uranium stockpiles and sanctions, remains critical for reducing volatility and enabling a decisive upward move in the market.
| Index | Close (May 18) | Change (May 18) | Previous Close |
|---|---|---|---|
| NIFTY 50 | 23,649 | +0.03% | 23,636 |
| BSE Sensex | 75,263 | +0.03% | 75,240 |
| Nifty Midcap 100 | 14,419 | -0.22% | 14,482 |
| Nifty Smallcap 100 | 9,123 | -1.26% | 9,242 |
Investor Takeaway
Investors should focus on tech and pharma stocks for potential gains.
More in Market
Market Analysis: Key Stocks to Watch - Narayana Hrudayalaya, ABB India, Federal Bank, Premier Energies, Ather Energy and More
FirstClub Secures $55 Million in Funding from Peak XV, Sofina, and Other Investors 9 Months After $22 Million Series A Round
Global Markets: Key Indicators to Monitor in Today's Trading Session
